Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 607.80 million Euro [US$643.18 million]
of which 51%
was Non-Proprietary Homeopathic Medicines),
(488.74 million Euro [US$517.18 million]
of which 43%
was X-rays), and
(342.61 million Euro [US$362.55 million]
of which 60%
was Operating Segment - Europe).
Virbac reported sales of 852.62 million Euro (US$902.25 million)
December of 2015.
increase of 10.3%
versus 2014, when the company's sales were 773.12 million Euro.
Sales at Virbac have increased during each of the previous five years
(and since 2010, sales have increased a total of 49%).
Sales of Companion Animals saw an increase
14.3% in 2015, from
418.10 million Euro to 477.80 million Euro.
Not all segments of Virbac experienced an increase in sales in 2015:
sales of Other fell 18.4% to 10.20 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).